Yes ... imagine the share price reaction if this had been released as an IMU announcement rather than the results of an independent study. Maybe Yuman Fong's name should have been highlighted!
Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid TumorChen, Courtney MD; Park, Anthony K PhD; Monroy, Isabel BS; Ren, Yuwei MS; Kim, Sang-In MS; Chaurasiya, Shyambabu PhD; Priceman, Saul J PhD; Fong, Yuman MD, FACS
Media Thread, page-12509
-
- There are more pages in this discussion • 3,337 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.001(1.02%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $303.2K | 6.188M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 125 | 17545263 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 873959 | 19 |
View Market Depth
| Last trade - 14.20pm 21/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |